{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:10:49Z","timestamp":1790856649415,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001439"],"award-info":[{"award-number":["UL1 TR001439"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00774-023-01475-2","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T13:02:08Z","timestamp":1701954128000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phenytoin is associated with increased risk of osteoporosis and fragility fractures in adult epileptic patients"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2756-9969","authenticated-orcid":false,"given":"Sterling J.","family":"DeShazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garett L.","family":"Ozmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","volume":"8","author":"RH Lee","year":"2010","unstructured":"Lee RH, Lyles KW, Col\u00f3n-Emeric C (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 8:34\u201346. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.02.003. (PMID: 20226391; PMCID: PMC3570810)","journal-title":"Am J Geriatr Pharmacother"},{"key":"1475_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.yebeh.2004.02.005","volume":"5","author":"II Ali","year":"2004","unstructured":"Ali II, Schuh L, Barkley GL, Gates JR (2004) Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav 5:296\u2013300. https:\/\/doi.org\/10.1016\/j.yebeh.2004.02.005. (PMID: 15145297)","journal-title":"Epilepsy Behav"},{"key":"1475_CR3","first-page":"36","volume":"50","author":"A Siniscalchi","year":"2020","unstructured":"Siniscalchi A, Murphy S, Cione E, Piro L, Sarro G, Gallelli L (2020) Antiepileptic drugs and bone health: current concepts. Psychopharmacol Bull 50:36\u201344 (PMID: 32508365; PMCID: PMC7255839)","journal-title":"Psychopharmacol Bull"},{"key":"1475_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2220\/biomedres.38.297","volume":"38","author":"J Kanda","year":"2017","unstructured":"Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, Takahashi HE, Wakabayashi H (2017) Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats. Biomed Res 38:297\u2013305. https:\/\/doi.org\/10.2220\/biomedres.38.297. (PMID: 29070779)","journal-title":"Biomed Res"},{"key":"1475_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.eplepsyres.2016.10.005","volume":"128","author":"J Simko","year":"2016","unstructured":"Simko J, Karesova I, Kremlacek J, Fekete S, Zimcikova E, Malakova J, Zivna H, Valis M, Palicka V (2016) The effect of lamotrigine and phenytoin on bone turnover and bone strength: a prospective study in Wistar rats. Epilepsy Res 128:113\u2013118. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.10.005. (Epub 2016 Oct 24 PMID: 27838501)","journal-title":"Epilepsy Res"},{"key":"1475_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fneur.2014.00142","volume":"4","author":"SA Hamed","year":"2014","unstructured":"Hamed SA, Moussa EM, Youssef AH, Abd ElHameed MA, NasrEldin E (2014) Bone status in patients with epilepsy: relationship to markers of bone remodeling. Front Neurol 4:142. https:\/\/doi.org\/10.3389\/fneur.2014.00142. (PMID: 25136330; PMCID: PMC4120678)","journal-title":"Front Neurol"},{"key":"1475_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","volume":"99","author":"P Vestergaard","year":"1999","unstructured":"Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L (1999) Fracture risk is increased in epilepsy. Acta Neurol Scand 99:269\u2013275. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00675.x. (PMID: 10348155)","journal-title":"Acta Neurol Scand"},{"key":"1475_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bone.2019.06.030","volume":"127","author":"M Bellver","year":"2019","unstructured":"Bellver M, Del Rio L, Jovell E, Drobnic F, Trilla A (2019) Bone mineral density and bone mineral content among female elite athletes. Bone 127:393\u2013400. https:\/\/doi.org\/10.1016\/j.bone.2019.06.030. (Epub 2019 Jul 1 PMID: 31271933)","journal-title":"Bone"},{"key":"1475_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2015.05.002","volume":"44","author":"BC Lupsa","year":"2015","unstructured":"Lupsa BC, Insogna K (2015) Bone health and osteoporosis. Endocrinol Metab Clin North Am 44:517\u2013530. https:\/\/doi.org\/10.1016\/j.ecl.2015.05.002. (PMID: 26316240)","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1475_CR10","first-page":"351","volume":"39","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Ueda S, Umezu R, Matsuoka H, Sugihara S (2007) Evaluation of bone mineral density using digital image processing in children receiving anticonvulsants. No To Hattatsu 39:351\u2013355 (Japanese. PMID: 17879608)","journal-title":"No To Hattatsu"},{"key":"1475_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111393","volume":"142","author":"J Patocka","year":"2020","unstructured":"Patocka J, Wu Q, Nepovimova E, Kuca K (2020) Phenytoin - an anti-seizure drug: overview of its chemistry, pharmacology and toxicology. Food Chem Toxicol 142:111393. https:\/\/doi.org\/10.1016\/j.fct.2020.111393. (Epub 2020 May 4 PMID: 32376339)","journal-title":"Food Chem Toxicol"},{"key":"1475_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3349\/ymj.2014.55.2.417","volume":"55","author":"JH Baek","year":"2014","unstructured":"Baek JH, Seo YH, Kim GH, Kim MK, Eun BL (2014) Vitamin D levels in children and adolescents with antiepileptic drug treatment. Yonsei Med J 55:417\u2013421. https:\/\/doi.org\/10.3349\/ymj.2014.55.2.417","journal-title":"Yonsei Med J"},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.spen.2007.08.006","volume":"14","author":"EA Samaniego","year":"2007","unstructured":"Samaniego EA, Sheth RD (2007) Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 14:196\u2013200. https:\/\/doi.org\/10.1016\/j.spen.2007.08.006. (PMID: 18070676)","journal-title":"Semin Pediatr Neurol"},{"key":"1475_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/s0024-3205(01)01522-3","volume":"70","author":"K Onodera","year":"2002","unstructured":"Onodera K, Takahashi A, Sakurada S, Okano Y (2002) Effects of phenytoin and\/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci 70:1533\u20131542. https:\/\/doi.org\/10.1016\/s0024-3205(01)01522-3. (PMID: 11895104)","journal-title":"Life Sci"},{"key":"1475_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.tiv.2007.02.008","volume":"21","author":"SM von Borstel","year":"2007","unstructured":"von Borstel SM, Crofoot K, Rodriguez-Proteau R, Filtz TM (2007) Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells. Toxicol In Vitro 21:855\u2013862. https:\/\/doi.org\/10.1016\/j.tiv.2007.02.008. (Epub 2007 Feb 27 PMID: 17412555)","journal-title":"Toxicol In Vitro"},{"key":"1475_CR16","first-page":"32","volume":"9","author":"EM Parara","year":"2009","unstructured":"Parara EM, Galanopoulou PB, Rallis G, Vairaktaris E, Tesseromatis CP (2009) Mandibular bone density and calcium content affected by long-term anticonvulsant treatment in rats. J Musculoskelet Neuronal Interact 9:32\u201337 (PMID: 19240366)","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1475_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364\u2013376. https:\/\/doi.org\/10.1016\/S0140-6736(18)32112-3. (PMID: 30696576)","journal-title":"Lancet"},{"key":"1475_CR18","volume-title":"In: StatPearls","author":"JL Porter","year":"2022","unstructured":"Porter JL, Osteoporosis VM (2022) In: StatPearls. StatPearls Publishing, Treasure Island (FL) (PMID: 28722930)"},{"key":"1475_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N\u00c7 (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46\u201356. https:\/\/doi.org\/10.5152\/eurjrheum.2016.048. (Epub 2016 Dec 30. PMID: 28293453; PMCID: PMC5335887)","journal-title":"Eur J Rheumatol"},{"key":"1475_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106619","volume":"173","author":"DW Griepp","year":"2021","unstructured":"Griepp DW, Kim DJ, Ganz M, Dolphin EJ, Sotudeh N, Burekhovich SA, Naziri Q (2021) The effects of antiepileptic drugs on bone health: a systematic review. Epilepsy Res 173:106619. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106619. (Epub 2021 Mar 19 PMID: 33774428)","journal-title":"Epilepsy Res"},{"key":"1475_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jocd.2016.07.008","volume":"19","author":"B Shiek Ahmad","year":"2016","unstructured":"Shiek Ahmad B, O\u2019Brien TJ, Gorelik A, Hill KD, Wark JD (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom 19:450\u2013456. https:\/\/doi.org\/10.1016\/j.jocd.2016.07.008. (Epub 2016 Aug 20 PMID: 27553750)","journal-title":"J Clin Densitom"},{"key":"1475_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1517\/14740331003636475","volume":"9","author":"KO Nakken","year":"2010","unstructured":"Nakken KO, Taub\u00f8ll E (2010) Bone loss associated with use of antiepileptic drugs. Expert Opin Drug Saf 9:561\u2013571. https:\/\/doi.org\/10.1517\/14740331003636475. (PMID: 20201711)","journal-title":"Expert Opin Drug Saf"},{"key":"1475_CR23","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/epi.12351","volume":"54","author":"AA Lazzari","year":"2013","unstructured":"Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM (2013) Prevention of bone loss and vertebral fractures in patients with chronic epilepsy\u2013antiepileptic drug and osteoporosis prevention trial. Epilepsia 54:1997\u20132004. https:\/\/doi.org\/10.1111\/epi.12351. (Epub 2013 Sep 6 PMID: 24010637)","journal-title":"Epilepsia"},{"key":"1475_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.18071\/isz.74.0257","volume":"74","author":"FE U\u00e7an Toku\u00e7","year":"2021","unstructured":"U\u00e7an Toku\u00e7 FE, Fatma G, Abidin E, Yasemin GB (2021) Management of bone metabolism in epilepsy. Ideggyogy Sz 74:257\u2013265. https:\/\/doi.org\/10.18071\/isz.74.0257. (PMID: 34370412)","journal-title":"Ideggyogy Sz"},{"key":"1475_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/14740338.2014.919255","volume":"13","author":"B Miziak","year":"2014","unstructured":"Miziak B, B\u0142aszczyk B, Chro\u015bci\u0144ska-Krawczyk M, Danilkiewicz G, Jagie\u0142\u0142o-W\u00f3jtowicz E, Czuczwar SJ (2014) The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opin Drug Saf 13:935\u2013946. https:\/\/doi.org\/10.1517\/14740338.2014.919255. (Epub 2014 May 12 PMID: 24821596)","journal-title":"Expert Opin Drug Saf"},{"key":"1475_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00198-006-0185-z","volume":"18","author":"SJ Petty","year":"2007","unstructured":"Petty SJ, O\u2019Brien TJ, Wark JD (2007) Anti-epileptic medication and bone health. Osteoporos Int 18:129\u2013142. https:\/\/doi.org\/10.1007\/s00198-006-0185-z. (Epub 2006 Nov 8 PMID: 17091219)","journal-title":"Osteoporos Int"},{"key":"1475_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2010.07.007","volume":"64","author":"AH Warriner","year":"2011","unstructured":"Warriner AH, Patkar NM, Curtis JR, Delzell E, Gary L, Kilgore M, Saag K (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64:46\u201353. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.007. (PMID: 21130353; PMCID: PMC5030717)","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01475-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-023-01475-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01475-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T07:05:41Z","timestamp":1707462341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-023-01475-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s00774-023-01475-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no declarations to make at this time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval and\/or informed consent was not sought out for this study as it solely utilizes deidentified patient information from the TriNetX database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}